{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-105306","form_type":"8-K","ticker":"CYDY","cik":"0001175680","company_name":"CytoDyn Inc.","filed_at":"2025-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.934569+00:00","generated_at":"2026-05-17T00:50:06.442496+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CytoDyn secures $30M equity funding commitment from Yorkville Advisors over 36 months","bullets":["Up to $30M in common stock sales to Yorkville over 36 months; company controls timing, no minimum draws.","Shares priced at 98% of lowest 3-day VWAP; Yorkville capped at 4.99% beneficial ownership.","Commitment fee of 1% paid in shares (half immediately, half at 6 months); structuring fee $25k.","Proceeds for working capital, debt repayment, and leronlimab PD-L1 program development.","No warrants or derivatives; registration statement to be filed for resale."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-105306","json":"https://secwatch.observer/filing/0001104659-25-105306.json","markdown":"https://secwatch.observer/filing/0001104659-25-105306.md","text":"https://secwatch.observer/filing/0001104659-25-105306.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175680/000110465925105306/0001104659-25-105306-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175680/000110465925105306/cydy-20251103x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:50:06.442496+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}